Skip to main content
Home
Drug Metabolic Roadmap (2024 update)
★
Drug Metabolic Roadmap
★
Drug Metabolite
★
Metabolic Reaction
DME Interactome
Microbiome-DME Interaction
Host Protein-DME Interaction
Xenobiotics-DME Interaction
Download
Help
Drug Information
Drug General Information
Drug ID
D0M1OE
Former ID
DNC013483
Drug Name
ANOLOBINE
Drug Type
Small molecular drug
Indication
Discovery agent
Investigative
[
528616
]
Formula
C17H15NO3
Canonical SMILES
C1CNC2CC3=C(C=CC(=C3)O)C4=C2C1=CC5=C4OCO5
InChI
1S/C17H15NO3/c19-11-1-2-12-10(5-11)6-13-15-9(3-4-18-13)7-14-17(16(12)15)21-8-20-14/h1-2,5,7,13,18-19H,3-4,6,8H2/t13-/m1/s1
InChIKey
LTSPCGWFQLHECP-CYBMUJFWSA-N
PubChem Compound ID
164710
Target and Pathway
Target(s)
Sodium-dependent dopamine transporter
Target Info
Inhibitor
[
551362
]
D(2) dopamine receptor
Target Info
Inhibitor
[
528616
]
KEGG Pathway
Dopaminergic synapse
Parkinson's disease
Cocaine addiction
Amphetamine addiction
Alcoholismhsa04015:Rap1 signaling pathway
cAMP signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Alcoholism
PANTHER Pathway
Adrenaline and noradrenaline biosynthesis
Parkinson disease
Dopamine receptor mediated signaling pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
Dopamine receptor mediated signaling pathway
Nicotine pharmacodynamics pathway
Pathway Interaction Database
Alpha-synuclein signaling
Reactome
Na+/Cl- dependent neurotransmitter transportersR-HSA-390651:Dopamine receptors
G alpha (i) signalling events
WikiPathways
Monoamine Transport
NRF2 pathway
Dopaminergic Neurogenesis
Parkinsons Disease Pathway
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
Neurotransmitter Clearance In The Synaptic CleftWP666:Hypothetical Network for Drug Addiction
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Genes and (Common) Pathways Underlying Drug Addiction
GPCR ligand binding
GPCR downstream signaling
Nicotine Activity on Dopaminergic Neurons
References
Ref 528616
J Med Chem. 2007 Jan 25;50(2):171-81.Advances in development of dopaminergic aporphinoids.
Ref 528616
J Med Chem. 2007 Jan 25;50(2):171-81.Advances in development of dopaminergic aporphinoids.
Ref 551362
Effects of various isoquinoline alkaloids on in vitro 3H-dopamine uptake by rat striatal synaptosomes. J Nat Prod. 1995 Oct;58(10):1475-84.
If you find any error in data or bug in web service, please kindly report it to
Dr. Yin
and
Dr. Li
.